ID17647A - Zat untuk propilaksis dan pengobatan untuk gangguan dari fungsi penglihatan - Google Patents

Zat untuk propilaksis dan pengobatan untuk gangguan dari fungsi penglihatan

Info

Publication number
ID17647A
ID17647A IDP972308A ID972308A ID17647A ID 17647 A ID17647 A ID 17647A ID P972308 A IDP972308 A ID P972308A ID 972308 A ID972308 A ID 972308A ID 17647 A ID17647 A ID 17647A
Authority
ID
Indonesia
Prior art keywords
propilactic
disorders
substance
treatment
vision function
Prior art date
Application number
IDP972308A
Other languages
English (en)
Inventor
Toshiharu Tsuboi
Noriko Watanabe
Takahiro Ogawa
Mitsuyoshi Isaka
Mitsunori Waki
Original Assignee
Takeda Chemical Industries Ltd
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd, Senju Pharma Co filed Critical Takeda Chemical Industries Ltd
Publication of ID17647A publication Critical patent/ID17647A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IDP972308A 1996-07-05 1997-07-03 Zat untuk propilaksis dan pengobatan untuk gangguan dari fungsi penglihatan ID17647A (id)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP17693396 1996-07-05
JP21394196 1996-08-13
JP31403396 1996-11-25

Publications (1)

Publication Number Publication Date
ID17647A true ID17647A (id) 1998-01-15

Family

ID=27324333

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP972308A ID17647A (id) 1996-07-05 1997-07-03 Zat untuk propilaksis dan pengobatan untuk gangguan dari fungsi penglihatan

Country Status (9)

Country Link
US (1) US5952338A (id)
EP (1) EP0819431A1 (id)
KR (1) KR980008226A (id)
CN (1) CN1172644A (id)
AU (1) AU2843397A (id)
BR (1) BR9703874A (id)
CA (1) CA2209581A1 (id)
HU (1) HUP9701150A2 (id)
ID (1) ID17647A (id)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794518B1 (en) 1998-12-18 2004-09-21 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
CN1247581C (zh) * 2000-11-20 2006-03-29 三共株式会社 卡巴培南类抗菌剂的制造方法
WO2002078673A1 (fr) * 2001-03-29 2002-10-10 Takeda Chemical Industries, Ltd. Procede de production d'un medicament sous forme de granules fins
WO2002078669A1 (fr) * 2001-03-30 2002-10-10 Takeda Chemical Industries, Ltd. Solutions medicinales
JP2003010158A (ja) * 2001-04-26 2003-01-14 Biochemical & Pharmacological Laboratories Inc 眼精疲労モデル、その作製方法、そのモデルを用いた評価方法およびその評価法を用いて選択された薬剤
FR2863496A1 (fr) * 2003-12-12 2005-06-17 Anben Pharma Composition therapeutique destinee au traitement des troubles de l'accomodation de l'oeil humain
US9827250B2 (en) * 2012-07-31 2017-11-28 Johnson & Johnson Vision Care, Inc. Lens incorporating myopia control optics and muscarinic agents
US20230277521A1 (en) * 2022-03-07 2023-09-07 Harrow Ip, Llc Extended-release pharmaceutical compositions for treating eye conditions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299963A (en) * 1977-03-08 1981-11-10 Takeda Chemical Industries, Ltd. 1-Azaxanthone derivatives
AU513456B2 (en) * 1977-03-08 1980-12-04 Takeda Chemical Industries Ltd. l-Azaxanthone-3-carboxylic acids
US4255576A (en) * 1977-03-08 1981-03-10 Takeda Chemical Industries, Ltd. 1-Azaxanthone derivatives
CA1095519A (en) * 1977-03-14 1981-02-10 Harold E. Zaugg Esters of 1,4-ethano-10-hydroxy-5-oxo-5h-[1] benzopyrano [3,4-b] pyridine
JPS5825677B2 (ja) * 1977-09-26 1983-05-28 武田薬品工業株式会社 3−テトラゾ−ル−1−アザキサントン誘導体およびその製造法
JPS6110588A (ja) * 1985-01-23 1986-01-18 Takeda Chem Ind Ltd 1−アザキサントン誘導体およびその製造法
JPS6110587A (ja) * 1985-01-23 1986-01-18 Takeda Chem Ind Ltd 1−アザキサントン−3−カルボン酸誘導体およびその製造法
US4728509A (en) * 1985-08-19 1988-03-01 Takeda Chemical Industries, Ltd. Aqueous liquid preparation
US5519030A (en) * 1993-10-07 1996-05-21 Senju Pharmaceutical Co., Ltd. Method for prophylaxis and treatment of myopia

Also Published As

Publication number Publication date
CA2209581A1 (en) 1998-01-05
US5952338A (en) 1999-09-14
AU2843397A (en) 1998-01-15
CN1172644A (zh) 1998-02-11
HUP9701150A2 (hu) 1999-02-01
KR980008226A (ko) 1998-04-30
BR9703874A (pt) 1998-09-01
EP0819431A1 (en) 1998-01-21
MX9705077A (es) 1998-05-31
HU9701150D0 (en) 1997-09-29

Similar Documents

Publication Publication Date Title
ID23600A (id) Turunan tiazolidin dan oksazolidin, pembuatan dan penggunaannya untuk pengobatan (pecahan dari p-950453)
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
DE69823459D1 (de) Herzbehandlungssystem zur Feststellung und Behandlung von Herzversagen
ID27859A (id) Tampon dan metoda pembuatannya
DE69833948D1 (de) Aktives system zur frühen zerstörung von schleppwirbeln
DE69838386D1 (de) Beleuchtungssystem und dessen anwendung
EE04280B1 (et) Imidasopürimidiinid ja imidasopüridiinid neuroloogiliste häirete käitlemiseks
NO306977B1 (no) Anvendelse av tienol[1,5]benzodiazepin for behandling av tilstander i mave/tarmkanalen
DE69841076D1 (de) System implantierbarer geräte zur beobachtung und beeinflussung von körperparametern
ID22807A (id) Hasil derifat 1-aril dan piridilpirazol untuk pestisida
ID17116A (id) Komposisi senyawa turunan 6-fenilpiridil-2-amina dan penggunaannya dalam pengobatan dan gangguan sistem syaraf pusat
PT936908E (pt) Derivados anticonvulsivos uteis no tratamento de esclerose lateral amiotrofica (ela)
NO963049D0 (no) Modulatorer av forankrende proteinfunksjon
NO20004098L (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
FI952721A7 (fi) Aine maksa-sappi-sairauksien hoitamiseksi
DE69731341D1 (de) Optisches Bauelement und optisches System mit diesem
BR9707922A (pt) Cafeína e clemastina para tratamento de distúrbios respiratórios
ID22283A (id) Kombinasi terapi baru dari zat-zat mirtazapin dan antipsikotik untuk perawatan atau propilaksis gangguan psikotik
NO991459D0 (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
NO984432D0 (no) FremgangsmÕte for behandling av migrenesmerte
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
DE69739190D1 (de) Arzneimittel zur behandlung von oculären kreislauferkrankungen
ATE346840T1 (de) Aminoalkylphenol-derivate zur behandlung von depression und gedächtnis-funktionsstörung